Vaccines for COVID-19: the current state of play
Field | Value | Language |
dc.contributor.author | Koirala, Archana | en_AU |
dc.contributor.author | Joo, Ye Jin | en_AU |
dc.contributor.author | Khatami, Ameneh | en_AU |
dc.contributor.author | Chiu, Clayton | en_AU |
dc.contributor.author | Britton, Philip N | en_AU |
dc.date.accessioned | 2020-07-09 | |
dc.date.available | 2020-07-09 | |
dc.date.issued | 2020 | en_AU |
dc.identifier.uri | https://hdl.handle.net/2123/22811 | |
dc.description.abstract | There is a strong consensus globally that a COVID-19 vaccine is likely the most effective approach to sustainably controlling the COVID-19 pandemic. An unprecedented research effort and global coordination has resulted in a rapid development of vaccine candidates and initiation of trials. Here, we review vaccine types, and progress with 10 vaccine candidates against SARS-CoV-2 – the virus that causes COVID-19 - currently undergoing early phase human trials. We also consider the many challenges of developing and deploying a new vaccine on a global scale, and recommend caution with respect to our expectations of the timeline that may be ahead. | en_AU |
dc.language.iso | en | en_AU |
dc.subject | COVID-19 | en_AU |
dc.subject | Coronavirus | en_AU |
dc.title | Vaccines for COVID-19: the current state of play | en_AU |
dc.type | Article | en_AU |
dc.identifier.doi | 10.1111/imj.14867 |
Associated file/s
There are no files associated with this item.
Associated collections